Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Five Prime Therapeutics Inc (NASDAQ:FPRX)

22.29
Delayed Data
As of 4:00pm ET
 +0.33 / +1.50%
Today’s Change
19.73
Today|||52-Week Range
49.30
+1.69%
Year-to-Date
No recent news for Five Prime Therapeutics Inc.

Today’s Trading

Previous close21.96
Today’s open22.10
Day’s range21.75 - 22.71
Volume441,268
Average volume (3 months)567,943
Market cap$635.3M
Data as of 4:00pm ET, 01/22/2018

Growth & Valuation

Earnings growth (last year)-126.44%
Earnings growth (this year)-127.55%
Earnings growth (next 5 years)--
Revenue growth (last year)-91.92%
P/E ratioNM
Price/Sales44.01
Price/Book1.54

Competitors

 Today’s
change
Today’s
% change
EPZMEpizyme Inc+1.15+7.54%
----
RTRXRetrophin Inc+0.57+2.31%
EDITEditas Medicine Inc+4.22+13.88%
Data as of 4:00pm ET, 01/22/2018

Financials

Next reporting dateMarch 27, 2018
EPS forecast (this quarter)-$1.23
Annual revenue (last year)$30.7M
Annual profit (last year)-$65.7M
Net profit margin-214.06%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Aron M. Knickerbocker
Chief Financial Officer &
Senior Vice President
Marc L. Belsky
Corporate headquarters
South San Francisco, California

Forecasts